Keynote presentation: the pharmacology of drug addiction

45
Drogas de abuso Drogas de abuso Jorge Hernán Ramírez. MD, MSc, PhD

Transcript of Keynote presentation: the pharmacology of drug addiction

Page 1: Keynote presentation: the pharmacology of drug addiction

Drogas de abuso Drogas de abusoJorge Hernán Ramírez. MD, MSc, PhD

Page 2: Keynote presentation: the pharmacology of drug addiction

!"#$%%&'()*+$&,%-.+/+$&$#01%&2+&3#14-+5&&&6#&%$&*78-9:)#&;&-#&*+;&8%27<1#&=%&+=7))79->?&!"#$"%&'()*+,-&."/0%,-&1233&

Page 3: Keynote presentation: the pharmacology of drug addiction

Contenidos

• Definición de adicción

• Mecanismos de adicción

• Criterios de adicción

• Tipos de sustancias de abuso

Page 4: Keynote presentation: the pharmacology of drug addiction

ADICCION

Desorden crónico y recurrente en el que la búsqueda y consumo

compulsivo de psicofármacos persiste sin importar las serias

consecuencias negativas que acompañan su uso.

Teorías de adicción

•  “Liking” ------ “Wanting”

•  Deficits en la corteza prefrontal

•  Factores ambientales – geneticos

•  Factores propios de la sustancia de abuso

Page 5: Keynote presentation: the pharmacology of drug addiction

ADICCION Dependencia a sustancias

•  Síntomas de tolerancia.

•  Síntomas de retirada.

•  Uso de una sustancia a mayores dosis y por periodos mas largos de lo planeado.

•  Deseos infructuosos de suspender o reducir su uso.

•  Gastar considerable tiempo y esfuerzo (y…. Dinero!) en conseguir la sustancia.

•  Reducción en actividades sociales, ocupacionales o recreacionales por consumir la sustancia.

•  Continuar el uso de la sustancia pese a los problemas sociales, económicos o de salud que acompañan su uso.

Page 6: Keynote presentation: the pharmacology of drug addiction

ADICCION

•  Mecanismos de tolerancia

•  Cambios fisiológicos y estructurales con el abuso de sustancias

•  “Priming” Recaida!!

•  “Craving”

Page 7: Keynote presentation: the pharmacology of drug addiction

Circuito de recompensa cerebral

Page 8: Keynote presentation: the pharmacology of drug addiction

Misuse of Drugs Act Classification

Page 9: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 10: Keynote presentation: the pharmacology of drug addiction
Page 11: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 12: Keynote presentation: the pharmacology of drug addiction

OPIOIDES

Page 13: Keynote presentation: the pharmacology of drug addiction
Page 14: Keynote presentation: the pharmacology of drug addiction
Page 15: Keynote presentation: the pharmacology of drug addiction
Page 16: Keynote presentation: the pharmacology of drug addiction
Page 17: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 18: Keynote presentation: the pharmacology of drug addiction

INTOXICACION POR COCAINA

SINTOMAS •  Ansiedad, delirios, alucinaciones, convulsiones •  Cefalea •  Midriasis •  Taquicardia •  Palidez

COMPLICACIONES •  ACV - HSA •  Rabdomiolisis •  Isquemia aguda de miembros inferiores (EVPA) •  Infarto •  Arritmias

Page 19: Keynote presentation: the pharmacology of drug addiction
Page 20: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 21: Keynote presentation: the pharmacology of drug addiction
Page 22: Keynote presentation: the pharmacology of drug addiction
Page 23: Keynote presentation: the pharmacology of drug addiction
Page 24: Keynote presentation: the pharmacology of drug addiction
Page 25: Keynote presentation: the pharmacology of drug addiction
Page 26: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 27: Keynote presentation: the pharmacology of drug addiction
Page 28: Keynote presentation: the pharmacology of drug addiction

ALCOHOL• Muy hidrosoluble

• Altisima absorción

• Aumenta GABA - Reduce glutamato

• Mecanismo de adicción: reducción crónica de GABA y aumento crónico de glutamato... Explicación del Delirium tremens

• Tratamiento de alcoholismo

• Mecanismos de tolerancia:NaturalMetabólicafuncional

Page 29: Keynote presentation: the pharmacology of drug addiction
Page 30: Keynote presentation: the pharmacology of drug addiction
Page 31: Keynote presentation: the pharmacology of drug addiction
Page 32: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 33: Keynote presentation: the pharmacology of drug addiction

KETAMINA

Page 34: Keynote presentation: the pharmacology of drug addiction

Mecanismo de acción de la ketamina

Page 35: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 36: Keynote presentation: the pharmacology of drug addiction
Page 37: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 38: Keynote presentation: the pharmacology of drug addiction
Page 39: Keynote presentation: the pharmacology of drug addiction
Page 40: Keynote presentation: the pharmacology of drug addiction

Campañas antitabaco

Page 41: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales

Page 42: Keynote presentation: the pharmacology of drug addiction

Marihuana

Canabinoides

Receptor de anandamida

THC

+

Page 43: Keynote presentation: the pharmacology of drug addiction

Marihuana

Page 44: Keynote presentation: the pharmacology of drug addiction

Potenciales Usos de la Marihuana

•  Analgésico

•  Espasmolitico

•  Enfermedades neurodegenerativas

•  Accidente cerebrovascular

Page 45: Keynote presentation: the pharmacology of drug addiction

Nutt D, et al. The Lancet.

Mean independent group scores in each of the three categories of harm, for 20 substances, ranked by their overall score, and mean scores for each of the three subscales